ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 770,95
0,48%
Dow Jones
43 930,48
1,02%
DAX
21 042,00
0,18%
Brent Oil
78,52
-0,88%
Bitcoin
107 036,34
4,91%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Achilles Therapeutics PLC (ACHL) Cours

Achilles Therapeutics PLC

Achilles Therapeutics PLC (ACHL)

NASDAQ
1,1423
0,0023
( 0,20% )
Mis à jour : 19:15:15
Retardé de 15 minutes

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Statistiques et détails clés

Dernier
1,1423
Prix Achat
1,14
Prix Vente
1,15
Volume échangé
39 387
1,1206 Fourchette du Jour 1,16
0,00 Plage de 52 semaines 0,00
Cap du marché
46,929M
Clôture Veille
1,14
Ouverture
1,13
Dernière Transaction
15
@
1.145
Dernière heure de transaction
19:30:09
Volume financier
US$ 44 749
VWAP
1,1361
Volume moyen (3 m)
-
Actions en circulation
41 082 948
Rendement du Dividende
-
Ratio Cours sur Bénéfices
0,00
Bénéfice par action (BPA)
-
Chiffre d'affairess
6,08M
Bénéfice net
-69,67M

À propos de Achilles Therapeutics PLC

Achilles Therapeutics PLC is a biopharmaceutical company. It is developing novel cancer immunotherapies targeting clonal neoantigens. The company has two ongoing trials, the CHIRON trial in patients with advanced non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastati... Achilles Therapeutics PLC is a biopharmaceutical company. It is developing novel cancer immunotherapies targeting clonal neoantigens. The company has two ongoing trials, the CHIRON trial in patients with advanced non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
www.achillestx.com
Siège social
London, Gbr
Fondé
-
Achilles Therapeutics PLC est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker ACHL. Le dernier cours de clôture d'Achilles Therapeutics était de US$1,14. Au cours de la dernière année, les actions de Achilles Therapeutics ont été négociées dans une fourchette de prix de US$ 0,00 à US$ 0,00.

Achilles Therapeutics compte actuellement 41 082 948 actions en circulation. La capitalisation boursière d'Achilles Therapeutics est de US$46,83 million.

ACHL Dernières nouvelles

Plus de nouvelles

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

06 Janvier 2025
Edgar (US Regulatory)

Achilles Therapeutics Announces Sale of Technology Assets to AstraZeneca

- Proprietary data and samples from TRACERx and Achilles’ Material Acquisition Platform (MAP) will be transferred to AstraZeneca under the Transaction - - Conclusion of Strategic Review - LONDON...

24 Décembre 2024
GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

02 Décembre 2024
Edgar (US Regulatory)

Achilles Therapeutics Receives Approval to Transfer to Nasdaq Capital Market

LONDON, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL) today announced that on November 15, 2024, the Listing Qualifications department of the Nasdaq Stock Market...

19 Novembre 2024
GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

14 Novembre 2024
Edgar (US Regulatory)

Achilles Therapeutics Reports Third Quarter 2024 Financial Results

– Cash position of $86.1 million as of September 30, 2024, not including cash R&D tax credit of $12.8 million received in October 2024 –         LONDON, Nov. 14, 2024 (GLOBE NEWSWIRE...

14 Novembre 2024
GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

19 Septembre 2024
Edgar (US Regulatory)

Achilles Therapeutics Announces Strategic Update

–Achilles to discontinue development of TIL-based cNeT therapy– –Cash position of $95.1 million as of June 30, 2024– –BofA Securities engaged to provide strategic financial advice–        ...

19 Septembre 2024
GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

14 Août 2024
Edgar (US Regulatory)

Achilles Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Updates

– Announced research collaboration with Arcturus Therapeutics to explore second-generation mRNA cancer vaccines using Achilles’ AI-powered, tumor-targeting technology – – Provided interim Phase...

14 Août 2024
GlobeNewswire Inc.
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

ACHL - Frequently Asked Questions (FAQ)

What is the current Achilles Therapeutics share price?
The current share price of Achilles Therapeutics is US$ 1,1423
How many Achilles Therapeutics shares are in issue?
Achilles Therapeutics has 41 082 948 shares in issue
What is the market cap of Achilles Therapeutics?
The market capitalisation of Achilles Therapeutics is USD 46,83M
What is the 1 year trading range for Achilles Therapeutics share price?
Achilles Therapeutics has traded in the range of US$ 0,00 to US$ 0,00 during the past year
What is the reporting currency for Achilles Therapeutics?
Achilles Therapeutics reports financial results in USD
What is the latest annual turnover for Achilles Therapeutics?
The latest annual turnover of Achilles Therapeutics is USD 6,08M
What is the latest annual profit for Achilles Therapeutics?
The latest annual profit of Achilles Therapeutics is USD -69,67M
What is the registered address of Achilles Therapeutics?
The registered address for Achilles Therapeutics is 245 HAMMERSMITH ROAD, LONDON, W6 8PW
What is the Achilles Therapeutics website address?
The website address for Achilles Therapeutics is www.achillestx.com
Which industry sector does Achilles Therapeutics operate in?
Achilles Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
USEGUS Energy Corp
US$ 4,33
(86,64%)
88,29M
ASSTAsset Entities Inc
US$ 0,8404
(80,93%)
241,89M
GCTKGlucoTrack Inc
US$ 0,1216
(43,23%)
442,68M
DOGZDogness International Corporation
US$ 25,57
(41,27%)
1,33M
WKEYWISeKey International Holdings AG
US$ 9,985
(35,67%)
2,7M
GOEVCanoo Inc
US$ 0,3631
(-73,10%)
34,12M
HEPAHepion Pharmaceuticals Inc
US$ 0,30
(-36,03%)
587,04k
ORKTOrangeKloud Technology Inc
US$ 0,7619
(-31,97%)
6,12M
WNWMeiwu Technology Company Ltd
US$ 0,267
(-27,35%)
8,4M
FTAIFTAI Aviation Ltd
US$ 83,8972
(-25,35%)
13,4M
GCTKGlucoTrack Inc
US$ 0,12203
(43,73%)
443,83M
CRKNCrown Electrokinetics Corporation
US$ 0,1192
(-4,64%)
354,74M
ASSTAsset Entities Inc
US$ 0,8492
(82,82%)
241,92M
RGTIRigetti Computing Inc
US$ 13,125
(33,52%)
174,3M
RIMEAlgorhythm Holdings Inc
US$ 0,035
(-15,87%)
143,64M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
ACHL
Achilles Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés